Your browser does not support iframes.
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Forest Laboratories, Inc.
(NY:
FRX
)
38.53
USD
-0.17 (-0.44%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
991,305
Open
38.74
Bid (Size)
35.06 (100)
Ask (Size)
40.00 (100)
Prev. Close
38.70
Today's Range
38.43 - 38.81
52wk Range
31.28 - 39.09
Shares Outstanding
266,284,246
Dividend Yield
N/A
Top News
More News
Forest to Present Aclidinium Bromide and Roflumilast Clinical Data at the American Thoracic Society (ATS) International Conference
May 17, 2013
from
Business Wire News Releases
Forest Labs Will Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting
May 16, 2013
Forest Laboratories, Inc. (NYSE: FRX ), today announced it will be presenting data on two late-stage development products, cariprazine and levomilnacipran, at the American Psychiatric Association (APA)...
Read More
category
Benzinga
,
FRX
,
News
from
Latest Articles from Benzinga.com
More News
Read More
Forest Laboratories, Inc. to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting
May 16, 2013
from
Business Wire News Releases
Carl Icahn's Q1 13F Reveals Little New
May 15, 2013
from
StreetInsider.com News Articles
Watch for Continued Gains in Shares of Forest Laboratories (FRX)
May 15, 2013
from
Comtex SmarTrend® News Briefs
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013
May 14, 2013
from
Business Wire News Releases
Analyst Moves: MU, FRX, AES, CVC
May 10, 2013
category
Stocks
from
Market News Video
Today’s Research on DCTH, AKRX, ASTX, BMRN, and FRX
May 10, 2013
from
ACCESSWIRE
BMO Capital Starts Forest Laboratories (FRX) at Underperform
May 09, 2013
from
StreetInsider.com News Articles
Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 for the Treatment of Acute Heart Failure
May 09, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.